Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Phase II clinical trial of six mercaptopurine (6MP) and methotrexate in patients with BRCA-defective tumors.

Journal article

Nicum S. et al, (2013), JOURNAL OF CLINICAL ONCOLOGY, 31

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.

Journal article

Kerr DJ. et al, (2007), N Engl J Med, 357, 360 - 369